News and Comments

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Merck (MRK) KERYX (KERX) GlaxoSmithKline (GSK) Elan (ELN) Regeneron (REGN) Abbott Laboratories (ABT) ZALTRAP™ Illumina (ILMN) Agenus (AGEN Human Longevity (HLI) Sangamo (SGMO) Ridaforolimus VANDA (VNDA) Jazz Pharmaceuticals (JAZZ) Herceptin AGOS (ARGS) Rapamune Benlysta (belimumab) Trastuzumab-DM1 Genentech Idenix (IDIX) Anacor (ANAC) SERES THERAPEUTICS (MCRB) Bellicum (BLCM) Roche (ROCHE) INNOVIVA (INVA) Sanofi-Aventis (SAN) Exelixis (EXEL) Micromet (MITI) Alder Biopharmaceuticals (ALDR) OSI (OSIP) Endometrial Cancer Galena (GALE) Xoma (XOMA) Auspex (ASPX) HALOZYME (HALO) Zerenex ARCA (ABIO) Sarepta (SRPT) Intermune (ITMN) AERIE PHARMACEUTICALS ADVENTRIX (ANX) ISIS (ISIS) Prolor Biotech (PBTH) Sequenom (SQNM) ImmunoGen (IMGN) Pluristem (PSTI) Theravance (THRX) Telaprevir Adaptimmune (ADAP) PTC Therapeutics (PTCT) Human Genome Sciences (HGSI) BIOMARIN (BMRN) RenenxBio (RGNX) IDERA (IDRA) REGULUS (RGLS) Cytokinetics (CYTK) Velcade (bortezomib) Inovio (INO) Multiple Myeloma Tysabri C4 Therapeutics Sanofi (SNY) MODERNA NANTKWEST (NK) NOVOCURE (NVCR) Editas (EDIT) Incyte (INCY) Array Pharmaceuticals (ARRY) Intercept (ICPT) Ionis (IONS) NEKTAR (NKTR)) Bristol-Myers Squibb (BMY) Ziofpharm (ZIOP) Biocryst (BCRX) Dynavax (DVAX) Amgen (AMGN) Revlimid (lenolidamide) CRISPR Therapeutics (CRSP) ARGOS (ARGS) Sanofi (SNA) Valeant Pharmaceuticals International (VRX) SYNTA (SNTA) Aimmune Therapeutics (AIMT) Gilead (GILD) TOKAI (TKAOI) Biogen Idec (BIIB) ACADIA (ACAD) Vertex (VRTX) Dendreon (DNDN) Advaxis (ADXS) Ariad (ARIA) Intrexon (XON) KITE (KITE) Anadys (ANDS) SUNESIS PHARMACEUTICALS (SNSS) AstraZeneca (AZN) Onyx (ONXX) Roche (RHHBY) ABBVIE (ABBV) Mirati Therapeutics (MRTX) CompuGen (CGEN) JUNO (JUNO) Alnylam (ALNY) Theravance Bio Pharma (TBPH) galapagos (GLPG) Vitae Pharmaceuticals (VTAE) Prosensa (RNA) Seattle Genetics (SGEN) Agenus (AGEN) Spike Therapeutics (ONCE) GUARDIAN HEALTH Global Cell Therapeutics (GBT)